在脏疾病中针对炎症和心血管终点的向药物疗法
Daniel M Huck1,2, Leo F Buckley3, Anil Chandraker4
1Cardiovascular Imaging Program, Departments of Medicine and Radiology.
Journal of cardiovascular pharmacology
|September 7, 2023
概括
慢性病 (CKD) 加快炎症,增加心血管和风险. 解决免疫失调提供了一个有希望的策略,以改善慢性病患者的心脏和脏的结果.
科学领域:
- 心血管科学 心血管科学
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性病 (CKD) 加快免疫系统的失调,导致全身炎症.
- 这种炎症加剧了血管炎症反应,加速了动脉样硬化,导致心脏和脏内皮功能障碍.
研究的目的:
- 通过解决免疫系统调节障碍,探索修改慢性病心脏结局的策略.
- 审查针对CKD炎症的当前和新兴药物治疗方法.
主要方法:
- 对针对CKD炎症的药物疗法的临床试验和证据的审查.
- 对抑制炎症体,细胞因子 (IL-1,IL-6) 和其他通路的治疗方法的分析.
- 在CKD中检查具有类型抗炎功效的药物.
主要成果:
- 针对炎症体和细胞因子 (IL-1,IL-6) 的药物治疗有希望,但需要更强大的临床试验数据.
- 现有的CKD治疗方法,如他类药物,SGLT2抑制剂和GLP-1激动剂,显示出抗炎功效.
- 针对IL-6,脂蛋白,烯碳酸受体和免疫细胞的新兴疗法需要进一步研究.
结论:
- 准免疫失调和炎症是改善CKD心脏和脏结局的关键策略.
- 进一步的临床试验对于验证新型抗炎疗法在CKD患者中的疗效至关重要.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
460
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
460
Antihypertensive Drugs: Direct Renin Inhibitors
677
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
677
Heart Failure Drugs: Diuretics
418
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
418
Acute Kidney Injury V: Interprofessional Care
25
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25
Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Chronic Kidney Disease III: Interprofessional Care
41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41


